Nova Science Publishers, 2017. — 145 p. (New Developments in Medical Research).
Amyloidosis is a result of the abnormal deposition of ‘amyloid’ resulting in the disruption of organ and tissue function, which can be localized or systemic, with the kidney being most frequently affected. This book discusses the risk factors, treatment options and clinical aspects of amyloidosis. Chapter One explores amyloid cardiomyopathy. Chapter Two summarizes current investigations utilizing RNAi and immunotherapy to target the amyloid protein itself. Chapter Three reviews genetic counseling as an important component of the treatment algorithm for amyloidosis. Chapter Four discusses tissue examination in a diagnostic procedure. Chapter Five reviews protein studies in light-chain amyloidosis.
Amyloid Cardiomyopathy
Novel Therapies for Amyloidosis in the Era of RNAi and Immunotherapy
Clinical Management of Amyloidosis: Genetic Counseling as an Important Component of the Treatment Algorithm
Tissue Examination in a Diagnostic Procedure
Protein Studies in Light-Chain Amyloidosis